{"nct_id":"NCT03424122","title":"INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2018-07-02","start_date_type":"ACTUAL","primary_completion_date":"2022-06-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["INCY"]}